Effect of sodium hypochlorite treatment on remineralization of human root dentine in vitro.
Dentine consists simplified of mineral and of several organic components. Sodium hypochlorite (NaOCl) is a well-known nonspecific proteolytic agent capable to remove organic material. The aim of this study was to investigate the influence of organic material removal from artificial dentine lesions by means of NaOCl pretreatment on subsequent remineralization with and without fluoride. Human root dentine samples were demineralized in an acidic gel (pH = 5) at 37 degrees C for 2 weeks. After 2 min of pretreatment with a 0.4, 2 or 10% NaOCl solution, the samples were remineralized in a 20 mM HEPES buffer (pH = 7) containing 1.5 mM Ca(2) and 0.9 mM phosphate with or without addition of 10 ppm F(-) as NaF at 37 degrees C for 8 days. Mineral profiles were assessed by means of transversal microradiography after diol treatment to avoid shrinkage caused by drying. In a separate experiments the dentine contraction caused by 10% NaOCl was assessed. The contraction (negligible for sound dentine) was found to be about 12% for the lesions. The remineralization results showed that pretreatment with a 10% NaOCl solution for 2 min, increased lesion remineralization. After NaOCl treatment, the amount of accumulated mineral increased by about 27% without F in the remineralization solution, and by about 4% with 10 ppm in solution. The in vitro results suggest that removal of organic materials from dentine lesions is an interesting approach to enhance remineralization.
Inaba
D
D
Department of Preventive Dentistry, Nagasaki University School of Dentistry, Nagasaki, Japan.
Ruben
J
J
Takagi
O
O
Arends
J
J
D000293:Adolescent; D002021:Buffers; D002118:Calcium / Q000008:administration & dosage / Q000627:therapeutic use; D002327:Cariostatic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D002648:Child; D003804:Dentin / Q000737:chemistry / Q000187:drug effects* / Q000473:pathology; D005459:Fluorides / Q000008:administration & dosage / Q000627:therapeutic use; D006531:HEPES; D006801:Humans; D008852:Microradiography; D008903:Minerals / Q000032:analysis; D016877:Oxidants / Q000008:administration & dosage / Q000627:therapeutic use*; D010710:Phosphates / Q000008:administration & dosage / Q000627:therapeutic use; D012969:Sodium Fluoride / Q000008:administration & dosage / Q000627:therapeutic use; D012973:Sodium Hypochlorite / Q000008:administration & dosage / Q000627:therapeutic use*; D017001:Tooth Demineralization / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology; D014089:Tooth Remineralization / Q000379:methods*; D014092:Tooth Root / Q000737:chemistry / Q000187:drug effects* / Q000473:pathology
D002021:Buffers; D002327:Cariostatic Agents; D008903:Minerals; D016877:Oxidants; D010710:Phosphates; D012969:Sodium Fluoride; D012973:Sodium Hypochlorite; D005459:Fluorides; D006531:HEPES; D002118:Calcium